$Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers$

Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers

Bibliographic Details
Main Authors:	de Vries, F., van Staa, T.-P., Leufkens, H. G. M.
Format:	Online
Language:	English
Published:	Springer-Verlag 2010
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073046/

Similar Items

Proton pump inhibitors and gastroenteritis
by: Hassing, Robert-Jan, et al.
Published: (2016)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
by: Shin, Jai Moo, et al.
Published: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
by: Lemon, Thomas I
Published: (2013)

Use and overuse of proton pump inhibitors
by: Staiano, Annamaria, et al.
Published: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
by: Tin, Sim Sai, et al.
Published: (2014)

The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database
by: Bazelier, Marloes T, et al.
Published: (2011)

The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
by: Boardman, Helen F., et al.
Published: (2015)

The prevalence of co-administration of clopidogrel and proton pump inhibitors
by: Shrestha, Kajal, et al.
Published: (2011)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
by: Holla, Anantha Prasad, et al.
Published: (2011)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
by: Hansen, Karen E, et al.
Published: (2010)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
by: Lin, Eugene, et al.
Published: (2010)

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias
by: El-Charabaty, Elie, et al.
Published: (2013)

Acute interstitial nephritis due to proton pump inhibitors
by: Sampathkumar, K., et al.
Published: (2013)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
by: Juurlink, David N., et al.
Published: (2013)

Proton-Pump Inhibitors Therapy and Blood Pressure Control
by: Pedro Joya-Vazquez, et al.
Published: (2014-09-01)

Proton pump inhibitors affect the gut microbiome
by: Imhann, Floris, et al.
Published: (2016)

Proton pump inhibitors alter the composition of the gut microbiota
by: Jackson, Matthew A, et al.
Published: (2016)

Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients
by: Delcher, Anne, et al.
Published: (2015)

Proton pump inhibitors: A balanced view
by: Ramakrishna, B.S.
Published: (2015)

Dexlansoprazole – a new-generation proton pump inhibitor
by: Skrzydło-Radomańska, Barbara, et al.
Published: (2015)

Proton pump inhibitors for the treatment of cancer in companion animals
by: Walsh, Megan, et al.
Published: (2015)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
by: Swaminathan, Krishnan
Published: (2015)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
by: Alsalahi, Omran, et al.
Published: (2015)

Is hypomagnesemia associated with using proton pump inhibitors?
by: Yi, Joo-Hark, et al.
Published: (2016)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
by: Nishizawa, Toshihiro, et al.
Published: (2012)

Proton pump inhibitor prescribing patterns in the UK: a primary care database study
by: Othman, Fatmah, et al.
Published: (2016)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
by: Gjestad, Caroline, et al.
Published: (2015)

Long-Term Proton Pump Inhibitor Therapy and Falls and Fractures in Elderly Women: A Prospective Cohort Study
by: Lewis, J.R., et al.
Published: (2014)

Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
by: Khalili, Hamed, et al.
Published: (2012)

Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
by: de Vries, F., et al.
Published: (2007)

Reducing the cost of proton pump inhibitors by adopting best practice
by: Hughes, Jeff, et al.
Published: (2009)

Epidemiology of proton pump inhibitors therapy: an examination of the use and safety in general practice
by: Othman, Fatmah
Published: (2017)

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
by: Nies, Anne T., et al.
Published: (2011)

Effects of Proton Pump Inhibitors and H2 Receptor Antagonists on the Ileum Motility
by: Kurt, Atilla, et al.
Published: (2011)

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
by: Sharma, Rakesh K, et al.
Published: (2010)

Anti-Inflammatory and Anti-Oxidative Properties of Proton Pump Inhibitors
by: Naito, Yuji
Published: (2007)

Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor
by: Srivastava, Pratima
Published: (2012)

The Necessity of Validated Questionnaires: Determining Accurate Responses to Proton Pump Inhibitor Use
by: Jung, Kee Wook
Published: (2012)

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
by: Mistry, Suresh D., et al.
Published: (2011)

Influence of Proton Pump Inhibitors on Dexamethasone-Induced Gastric Mucosal Damage in Rats
by: Swamy, A. H. M. Viswanatha, et al.
Published: (2011)